Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,778 total articles

Immutep Receives Nasdaq Notice of Bid Price Deficiency

Immutep Receives Nasdaq Notice of Bid Price Deficiency

Immutep Limited announced it has received a Nasdaq notice for not meeting the minimum $1.00 bid price requirement for its American Depositary Shares (ADS) over 30 consecutive business days. The company has 180 days to regain compliance, or risk delisting. The company continues to be listed on the Australian Securities Exchange (ASX) without impact.

Immutep Quarterly Activities Report Q3 FY26

Immutep Quarterly Activities Report Q3 FY26

Immutep Limited announced the discontinuation of its TACTI-004 Phase III trial evaluating eftilagimod alfa in first-line non-small cell lung cancer due to futility findings. The company is conducting a root cause analysis to understand the unexpected poor performance of the combination therapy and assessing implications for the broader eftilagimod …

Integer Announces Strategic Review to Maximize Stockholder Value

Integer Announces Strategic Review to Maximize Stockholder Value

Integer Holdings Corporation announced that its Board of Directors has launched a strategic review to evaluate a full range of opportunities, including a potential sale, merger, or strategic business combination, aiming to maximize value for shareholders. The Board remains confident in Integer's standalone strategy but is responding to strong inter…

ITW Reports First Quarter 2026 Results

ITW Reports First Quarter 2026 Results

Illinois Tool Works Inc. reported solid first quarter 2026 results with revenue of $4.02 billion representing a 5% increase. Operating margin improved to 25.4%, driving a 12% increase in GAAP EPS to $2.66. The company raised its full-year 2026 GAAP EPS guidance to a range of $11.10 to $11.50, indicating strong confidence in continued growth and mar…

ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026

ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026

ALX Oncology announced new data from its Phase 1b/2 trial of evorpacept combined with zanidatamab will be presented at the ESMO Breast Cancer 2026 Congress, highlighting biomarker analyses predictive of response in HER2-positive metastatic breast cancer. The company also plans to report Q1 2026 financial results and host a conference call with expe…

GPGI Announces Date of First Quarter 2026 Earnings Call

GPGI Announces Date of First Quarter 2026 Earnings Call

GPGI, Inc. announced that it will hold its first quarter 2026 earnings conference call on May 7, 2026, to discuss financial results for the period ending March 31, 2026. The call will include a Q&A session and a prior press release detailing earnings. GPGI is a diversified, multi-industry company operating under a permanent capital base with a focu…

Atlantic International’s Circle8 Recognized as One of the Fastest-Growing IT and Technology Solutions Platforms in the Netherlands

Atlantic International’s Circle8 Recognized as One of the Fastest-Growing IT and Technology Solutions Platforms in the Netherlands

Atlantic International Corp announced its subsidiary Circle8 Netherlands achieved a top-five ranking among Dutch workforce solutions firms and a 15.2% organic growth rate, generating $1.4 billion annual gross revenue. This growth supports Atlantic's ongoing expansion in IT and technology services across Europe, including AI, cybersecurity, and data…

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

Solid Biosciences Inc. announced its largest scientific presence at the 29th Annual Meeting of the American Society of Gene & Cell Therapy, with 5 oral presentations and 11 posters showcasing advancements in its gene therapy pipeline targeting neuromuscular and cardiac diseases. The presentations reflect progress in clinical development, delivery t…

Commerce Introduces New Product Innovations Across Storefronts, B2B, Payments and AI-Driven Commerce at Commerce Live 2026

Commerce Introduces New Product Innovations Across Storefronts, B2B, Payments and AI-Driven Commerce at Commerce Live 2026

Commerce (Nasdaq: CMRC) announced a broad range of product innovations at Commerce Live 2026 aimed at enhancing core platform capabilities, expanding storefront and B2B functionalities, elevating payment solutions, and introducing AI-driven agentic commerce features. The company highlighted improvements such as multi-language support, advanced prom…

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

OPKO Health’s subsidiary, BioReference Health LLC, announced the launch of BioReference Direct, a new digital platform allowing consumers to order high-quality laboratory tests online without needing an in-office visit. This platform includes tests for general wellness, men’s and women’s health, and an at-home self-collection STI test in collaborat…

First National Corporation Reports First Quarter 2026 Earnings

First National Corporation Reports First Quarter 2026 Earnings

First National Corporation (NASDAQ: FXNC), the bank holding company of First Bank, reported net income of $4.9 million and diluted earnings per share of $0.54 for Q1 2026. The company exceeded budgeted metrics despite a challenging start, driven by increased loan production in March and strong deposit growth at an 8.4% annualized rate. Asset qualit…

Banco Santander-Chile Announces First Quarter 2026 Earnings

Banco Santander-Chile Announces First Quarter 2026 Earnings

Banco Santander Chile released its first quarter 2026 financial results, showcasing a solid performance with a 7.0% quarter-over-quarter profit growth and a return on average equity (ROAE) of 23.0%. The bank demonstrated growth in customer base and fees, effective expense management leading to improved efficiency, and maintained strong capital rati…

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology

Picard Medical, Inc., parent company of SynCardia Systems, highlights Banner Health's global leadership and extensive clinical experience in total artificial heart (TAH) therapy, having performed over 50 SynCardia Total Artificial Heart implants. The partnership underscores advancements in treating end-stage biventricular heart failure patients as …

INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th

INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th

INmune Bio Inc., a clinical-stage biotechnology company focusing on treatments targeting the innate immune system, announced it will release its financial results for Q1 2026 on May 7, 2026, along with a corporate update via conference call and webcast. The company has ongoing clinical programs targeting neuroinflammation related to Alzheimer's Dis…

Krystal Biotech to Present at Upcoming Scientific Conferences

Krystal Biotech to Present at Upcoming Scientific Conferences

Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology company specializing in genetic medicines, announced it will present new data and progress on several gene therapy programs at key scientific meetings in May and June 2026. The presentations cover treatments for primary ciliary dyskinesia, cystic fibrosis, and advanced non-small…

Retail Rush Consumer Marketplace Reaches $4 Million Annual Run Rate

Retail Rush Consumer Marketplace Reaches $4 Million Annual Run Rate

Retail Rush, an online buy-online pick-up-in-store consumer auction marketplace operated by Liquidity Services, has reached a $4 million annual revenue run rate since its September 2025 launch in Columbus, Ohio. Retail Rush's model of daily online auctions combined with local pickup has attracted a growing base of repeat customers and offers signif…